Virtus LifeSci Biotech Clinical Trials ETF
4 hedge funds and large institutions have $7.75M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$6.23M |
| 2 |
VKH
2
Virtu KCG Holdings
New York
|
$1.16M |
| 3 |
3
Jane Street
New York
|
$354K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$1K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $6.23M | 224,754 | +224,754 | New |
|
|
VKH
2
Virtu KCG Holdings
New York
| $1.16M | 41,727 | +41,727 | New |
|
|
3
Jane Street
New York
| $354K | 12,758 | +12,758 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $1K | 30 | +30 | New |
|